FOXM1 and cancer: FOXM1 inhibition efficiently sensitizes cancer cells to conventional chemotherapy, yet the often unknown inhibitory pathways of these compounds or their off-target actions exhibit undesired secondary effects like general proteasome inhibition or possible activity toward other targets, especially other FOX proteins.